实证分析我国假药非法流通的特点与趋势及其监管对策  

Empirical Analysis on Characteristics and Trend of Illegal Circulation of Counterfeit Drugs and Its Monitoring Countermeasures in China

作　　者：张昊[1,2] 陈光金[2] 

机构地区：[1]国家食品药品监督管理总局高级研修学院,北京100073 [2]中国社会科学院社会学所,北京100732

出　　处：《中国药房》2016年第19期2599-2601,共3页China Pharmacy

摘　　要：目的:了解当前我国假药非法流通的特点与趋势,并提出相应的监管对策。方法:采用实证研究方法,对我国制售假药的3个典型案例(江苏无锡市互联网跨国制售假药案、上海市阿瓦斯汀眼药案和四川达州市假药案)进行分析,并对假药的来源和非法流通途径进行比较,找出药品监管中存在的问题。结果与结论:我国假药非法流通的主要原因是对国内的外资医疗机构药品流通监管缺失、城镇医疗机构药品流通监管不到位、互联网销售假药监管手段落后以及患者对药品虚假信息识别能力不强等。建议建立国内外资医疗机构的药品管理规范,完善对基层医疗机构的药品流通监管,建立药品物流(运输)的许可制度,增强对网络销售假药信息的监测,加大信息公开力度。OBJECTIVE：To investigate the characteristics and trends of illegal circulation of counterfeit drugs in China,and to put forward monitoring countermeasures.METHODS：In empirical study,3 typical cases of counterfeit drugs manufacturing and selling in China were analyzed（including Jiangsu Wuxi Internet transnational counterfeit drugs manufacturing and selling case,Shanghai Avastin eye drug case,Sichuan Dazhou counterfeit drugs case）,to compare the sources of counterfeit drug and illegal circulation pathway,thus find out the monitoring problems.RESULTS CONCLUSIONS：Main reasons for illegal circulation of counterfeit drugs in China are as follows as drug circulation regulation absence of foreign-funded medical institutions,the existence of hidden drug circulation monitoring holes in urban medical institutions,under-developed and weak ability of distinguishing talse drug information internet counterfeit drugs sales regulatory means.It is suggested to establish drug management norms for foreign-funded medical institutions,improve drug circulation monitoring in primary medical institutions,establish pharmaceutical logistics（transportation）licensing system and strengthen online fake drug sale information monitoring and information publication.

关 键 词：假药 非法流通 监管对策 

分 类 号：R95[医药卫生—药学]